Biosceptre presenting our AML Modular CAR-T program at the prestigious European Hematological Congress Biosceptre presenting our AML Modular CAR-T program at the prestigious European Hematological CongressBiosceptre2025-06-19T12:55:07+10:00June 16th, 2025|News|Read More
Biosceptre’s BRiDGECAR™ Platform Recognised at Two Major Global Conferences! Biosceptre’s BRiDGECAR™ Platform Recognised at Two Major Global Conferences!Biosceptre2025-06-19T11:21:32+10:00May 12th, 2025|News|Read More
Professor Shane Grey Appointed Chairman of Biosceptre’s Scientific Advisory Board Professor Shane Grey Appointed Chairman of Biosceptre’s Scientific Advisory BoardBiosceptre2025-06-19T12:32:46+10:00March 1st, 2025|Corporate, News|Read More
Professor Shane Grey Joins the Biosceptre Scientific Advisory Board Professor Shane Grey Joins the Biosceptre Scientific Advisory BoardBiosceptre2025-06-19T12:33:29+10:00October 29th, 2024|Corporate, News|Read More
Biosceptre Secures Key U.S. Patent for Non-Functional P2X7 CAR-T Technology Biosceptre Secures Key U.S. Patent for Non-Functional P2X7 CAR-T TechnologyBiosceptre2025-06-19T12:21:16+10:00October 22nd, 2024|Corporate, News|Read More
Biosceptre meet with NSW Health Minister, Ryan Park Biosceptre meet with NSW Health Minister, Ryan ParkBiosceptre2023-12-01T16:41:40+11:00December 1st, 2023|Corporate, News|Read More
Biosceptre secures £7m. to boost novel CAR T therapy Biosceptre secures £7m. to boost novel CAR T therapyBiosceptre2021-03-31T15:15:21+11:00March 9th, 2021|Clinical, Corporate, News|Read More
Biosceptre boosts Australian biotech capacity with support for new lab Biosceptre boosts Australian biotech capacity with support for new labBiosceptre2021-03-31T14:36:56+11:00December 15th, 2020|News, Research|Read More
Biosceptre Signs Deal With Carina Biotech Biosceptre Signs Deal With Carina BiotechBiosceptre2020-10-02T11:13:22+10:00October 2nd, 2020|News|Read More
